Treatment of inflammatory bowel disease using histamine H.sub.3

Details Treatment of inflammatory bowel disease using histamine H.sub.3 Treatment of inflammatory bowel disease using histamine H.sub.3

1999-10-11

2000-02-22

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31415

Patent

active

060280956

ABSTRACT:
The present invention comprises a method for treating inflammatory bowel disease (IBD) by administering to a mammal in need thereof a therapeutically effective amount of at least one histamine H.sub.3 -receptor agonist. It has been unexpectedly found that H.sub.3 -receptor agonists are effective at alleviating the effects of IBD and, therefore, are useful for treating IBD, including ulcerative colitis and Crohn's disease.

REFERENCES:
patent: 5321039 (1994-06-01), Schwartz et al.
patent: 5463074 (1995-10-01), Shih et al.

Affiliated with

Also associated with

Rating

Treatment of inflammatory bowel disease using histamine H.sub.3 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of inflammatory bowel disease using histamine H.sub.3 , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of inflammatory bowel disease using histamine H.sub.3 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-520864